CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 2,850 shares at $20.00 ($57,000)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Executive Officer sold 12,563 shares at $19.59 ($246,109)
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 16,733 shares (grant or award)
- 4 Grant or award Director acquired 16,733 shares (grant or award)
- 4 Grant or award Director acquired 16,733 shares (grant or award)
- 4 Grant or award Director acquired 16,733 shares (grant or award)
- 4 Grant or award Director acquired 16,733 shares (grant or award)
- 4 Grant or award Director acquired 16,733 shares (grant or award)
- 4 Planned sale Chief Executive Officer sold 26,712 shares at an average $21.24 ($567,486)
- 424B7 Offering Prospectus
- 4 Planned sale Director sold 7,495 shares at an average $21.97 ($164,665)
- 4 Planned sale Director sold 5,547 shares at an average $21.91 ($121,556)
- 4 Planned sale Director sold 8,994 shares at $21.91 ($197,059)
- 144 Insider Sale of Securities
- 8-K Event Executive or director change
- 144 Insider Sale of Securities
Page 9 of 69 · 1,363 filings